Table 2.
Parameter | Units | Model training population | Model evaluation population |
---|---|---|---|
Patients | n | 350 | 323 |
Vancomycin levels | n | 1,549 | 1,290 |
Doses | n | 6,154 | 5,249 |
Levels per patient median, (range) | n | 2 (1–38) | 2 (1–49) |
Peak samples | n (%) | 16 (1.0%) | 15 (1.2%) |
Level value, median (range) | mg/L | 11 (1–56) | 11 (0–60) |
Percent male | % | 60.6 | 57.0 |
Age, median (range) | years | 3.5 (0.2–20.5) | 3.85 (0.2–20.2) |
Weight, median (range) | kg | 12.25 (2.1–110.6) | 15.1 (2.7–160.7) |
SCR at treatment start, median (range) | years | 0.3 (0.1–9.4) | 0.3 (0.1–9) |
SCR, creatinine.